Attached files

file filename
EX-3.01 - CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATI - MultiCell Technologies, Inc.v228552_ex3-1.htm
EX-10.1 - 2004 EQUITY INCENTIVE PLAN - MultiCell Technologies, Inc.v228552_ex10-1.htm
 


UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, DC 20549
 


FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

July 11, 2011
 


MULTICELL TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)

Delaware
 
001-10221
 
52-1412493
(State or other jurisdiction of incorporation)
 
(Commission  File Number)
 
(IRS Employer
Identification No.)

68 Cumberland Street, Suite 301
Woonsocket, Island 02895
(Address of principal executive offices, including zip code)

(401) 762-0045
(Registrant’s telephone number, including area code)

N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Consistent with the prior year, on July 11, 2011, the board of directors of MultiCell Technologies, Inc., or the Company, approved the grant of options to purchase shares of the Company’s common stock to each director in consideration for their board service as follows:
 
Name
 
Number of Shares
W. Gerald Newmin
 
1,000,000
Anthony E. Altig
 
1,000,000
Edward Sigmon
 
1,000,000
Thomas A. Page
 
1,000,000
Stephen Chang, Ph. D.
 
1,000,000

Twenty-five percent (25%) of the shares subject to each option shall vest on the last day of each quarter over the year following the date of grant, subject to the respective option holder’s continued service to the Company.

Item 5.07.
Submission of Matters to a Vote of Security Holders.
 
The Company held its Annual Meeting of Stockholders on July 11, 2011, to consider and vote on the matters listed below. The proposals are described in detail in the Proxy Statement filed with the Securities and Exchange Commission on June 15, 2011. The final voting results from the meeting are set forth below.
 
Proposal 1: Election of Directors
 
Based on the following votes, the individuals named below were each elected to serve as directors until the Company’s next annual meeting of stockholders.

Name
 
Votes For
   
Votes
Withheld
   
Broker Non-Votes
 
W. Gerald Newmin
    57,421,085       5,287,819       421,263,996  
Thomas A. Page
    57,696,837       5,012,067       421,263,996  
Edward Sigmond
    57,217,767       5,491,137       421,263,996  
Stephen Chang, Ph. D.
    58,625,688       4,083,216       421,263,996  
Anthony E. Altig
    57,410,767       5,298,137       421,263,996  
 
Proposal 2: Ratification of Selection of Independent Auditors
 
The proposal ratifies the selection of Hanson Barnett & Maxwell P.C. as the Company’s Independent Registered Public Accounting Firm. The results of the voting included 464,023,678 votes for, 4,017,049 votes against, 15,932,173 votes abstained and no non-votes. The selection was ratified.
 
Proposal 3: Approval of the Certificate of Amendment of the Company’s Amended and Restated Certificate of Incorporation
 
This proposal amends and restates the Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company’s common stock to a total of 1.25 billion shares and ratify certain prior increases in the number of authorized shares. The results of the voting included 378,917,055 votes for, 94,113,037 votes against, 10,942,808 votes abstained and no non-votes. The amendment was approved.
 
 
 

 

Proposal 4: Approval of the Amendment of the Company’s 2004 Equity Incentive Plan
 
This proposal amends the Company’s 2004 Equity Incentive Plan, or the Plan, to increase the number of shares reserved for the Plan to a total of 70,974,213, approve further annual increases in the number of shares reserved under the Plan, and ratify certain prior increases in the number of shares reserved for issuance under the Plan. The results of the voting included 42,757,109 votes for, 17,635,460 votes against, 2,316,335 votes abstained and 421,263,996 broker non-votes. The amendment was approved.

Item 9.01.
Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.
 
Description
3.01
 
Certificate of Amendment of the Amended and Restated Certificate of Incorporation
10.1
 
2004 Equity Incentive Plan, as amended
 
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

   
MULTICELL TECHNOLOGIES, INC.
     
 
By:
/s/ W. Gerald Newmin
 
   
W. Gerald Newmin
Chief Executive Officer, Chief Financial Officer

Date:  July 13, 2011